Zhengtong Lv

1.0k total citations · 1 hit paper
35 papers, 722 citations indexed

About

Zhengtong Lv is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhengtong Lv has authored 35 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Zhengtong Lv's work include Ferroptosis and cancer prognosis (11 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Cancer-related molecular mechanisms research (8 papers). Zhengtong Lv is often cited by papers focused on Ferroptosis and cancer prognosis (11 papers), Bladder and Urothelial Cancer Treatments (8 papers) and Cancer-related molecular mechanisms research (8 papers). Zhengtong Lv collaborates with scholars based in China, South Korea and Romania. Zhengtong Lv's co-authors include Yuan Chu, Huichuan Jiang, Jianye Wang, Haozhe Xu, Yuan Li, Yuan Li, Jingchao Liu, Miao Mo, Xiheng Hu and Yaoguang Zhang and has published in prestigious journals such as International Journal of Biological Macromolecules, Medicine and Journal of Cellular Biochemistry.

In The Last Decade

Zhengtong Lv

32 papers receiving 710 citations

Hit Papers

HIV protease inhibitors: a review of molecular selectivit... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HIV protease inhibitors: a review of molecular selectivity and toxicity
    2015 348 citations Zhengtong Lv et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhengtong Lv China 11 266 208 184 179 113 35 722
Robert R. LaBadie United States 21 234 0.9× 211 1.0× 171 0.9× 46 0.3× 33 0.3× 51 1.0k
Li‐Tain Yeh United States 22 419 1.6× 327 1.6× 98 0.5× 44 0.2× 89 0.8× 50 1.2k
Jia Guo United States 15 188 0.7× 72 0.3× 91 0.5× 53 0.3× 130 1.2× 43 757
Sarah L. Greig New Zealand 16 329 1.2× 121 0.6× 178 1.0× 34 0.2× 33 0.3× 28 932
Aixin Li China 13 199 0.7× 147 0.7× 62 0.3× 55 0.3× 55 0.5× 33 526
Steven Lacy United States 19 333 1.3× 134 0.6× 311 1.7× 114 0.6× 72 0.6× 29 1.2k
Richard de Boer Netherlands 11 273 1.0× 70 0.3× 171 0.9× 107 0.6× 42 0.4× 22 757
Nagdeep Giri United States 14 188 0.7× 119 0.6× 170 0.9× 24 0.1× 71 0.6× 23 633
Na Zhou China 17 191 0.7× 61 0.3× 169 0.9× 95 0.5× 22 0.2× 54 781
Yabo Ouyang China 15 238 0.9× 331 1.6× 24 0.1× 72 0.4× 59 0.5× 34 788

Countries citing papers authored by Zhengtong Lv

Since Specialization
Citations

This map shows the geographic impact of Zhengtong Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengtong Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengtong Lv more than expected).

Fields of papers citing papers by Zhengtong Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengtong Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengtong Lv. The network helps show where Zhengtong Lv may publish in the future.

Co-authorship network of co-authors of Zhengtong Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengtong Lv. A scholar is included among the top collaborators of Zhengtong Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengtong Lv. Zhengtong Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yongming, Xiaoying Wu, Yuxiao Jiang, et al.. (2025). Prevalence and Mortality Association of Different Stages of Cardiovascular-Kidney-Metabolic Syndrome. JACC Advances. 4(6). 101843–101843. 2 indexed citations
2.
3.
4.
Wang, Haoran, Zhengtong Lv, Haoran Xia, et al.. (2023). Cuproptosis-related long noncoding RNAs predicts overall survival and reveal immune microenvironment of bladder cancer. Heliyon. 9(12). e21153–e21153. 3 indexed citations
5.
Lv, Zhengtong, Miao Wang, Huimin Hou, et al.. (2023). FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway. International Journal of Biological Sciences. 19(11). 3293–3306. 9 indexed citations
6.
Liu, Jing, Xiaomei Gao, Jiaxian Chen, et al.. (2023). circWSB1 promotes tumor progression in ccRCC via circWSB1/miR-182-5p/WSB1 axis. International Journal of Biological Macromolecules. 256(Pt 1). 128338–128338. 4 indexed citations
7.
8.
Liu, Jingchao, Zhipeng Zhang, Wei Zhang, et al.. (2022). Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer. Frontiers in Cell and Developmental Biology. 10. 791630–791630. 9 indexed citations
9.
Liu, Jingchao, Wei Zhang, Jiawen Wang, et al.. (2022). Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer. Journal of Cancer Research and Clinical Oncology. 149(5). 1969–1983. 5 indexed citations
10.
Liu, Jingchao, Meng Wu, Wei Zhang, et al.. (2021). Comprehensive Analysis of N6-methyladenosine Modification Patterns Associated With Multiomic Characteristics of Bladder Cancer. Frontiers in Medicine. 8. 757432–757432. 7 indexed citations
11.
Lv, Zhengtong, Jianlong Wang, Xuan Wang, et al.. (2021). Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer. Frontiers in Cell and Developmental Biology. 9. 666025–666025. 29 indexed citations
12.
Xia, Haoran, Jianlong Wang, Jianlong Wang, et al.. (2021). Identification of a Hypoxia-Related Gene Signature for Predicting Systemic Metastasis in Prostate Cancer. Frontiers in Cell and Developmental Biology. 9. 696364–696364. 6 indexed citations
13.
14.
Qi, Lin, Jing Liu, Zhengtong Lv, et al.. (2021). Evaluation and analysis of incidence and risk factors of lower extremity venous thrombosis after urologic surgeries: A prospective two-center cohort study using LASSO-logistic regression. International Journal of Surgery. 89. 105948–105948. 56 indexed citations
15.
Lv, Zhengtong, Cheng Pang, Jinfu Wang, et al.. (2021). Identification of a prognostic signature based on immune-related genes in bladder cancer. Genomics. 113(3). 1203–1218. 5 indexed citations
16.
Liu, Jingchao, Hong Ma, Lingfeng Meng, et al.. (2021). Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer. Frontiers in Molecular Biosciences. 8. 675651–675651. 36 indexed citations
17.
Lv, Zhengtong, et al.. (2021). Zic Family Member 2 (ZIC2): a Potential Diagnostic and Prognostic Biomarker for Pan-Cancer. Frontiers in Molecular Biosciences. 8. 631067–631067. 24 indexed citations
18.
Lv, Zhengtong, et al.. (2020). Reduction of Bladder Volume after BCG Immunotherapy. Urologia Internationalis. 105(1-2). 155–158. 2 indexed citations
19.
Lv, Zhengtong, et al.. (2020). Impact of enhanced recovery after surgery or fast track surgery pathways in minimally invasive radical prostatectomy: a systematic review and meta-analysis. Translational Andrology and Urology. 9(3). 1037–1052. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert R. LaBadie Breakdown of academic impact, for papers by Li‐Tain Yeh Breakdown of academic impact, for papers by Jia Guo Breakdown of academic impact, for papers by Sarah L. Greig Breakdown of academic impact, for papers by Aixin Li Breakdown of academic impact, for papers by Steven Lacy Breakdown of academic impact, for papers by Richard de Boer Breakdown of academic impact, for papers by Nagdeep Giri Breakdown of academic impact, for papers by Na Zhou Breakdown of academic impact, for papers by Yabo Ouyang
Rankless by CCL
2026